Introduction
Aniridia is a severe congenital panocular disorder affecting the cornea, anterior chamber, iris, lens, retina, macula and optic nerve. It occurs as a result of haploinsufficiency in paired box gene PAX6 which is responsible for a proper eye development. The alterations in retina and development of glaucoma, cataract and keratopathy lead to a progressive deterioration of the visual acuity [1] . The underdeveloped iris and retina are examples of developmental defects. Other signs as glaucoma and cataract can be either congenital or develop after birth.
Aniridia associated keratopathy (AAK) typically develops in late childhood or later in life. The reason for this debilitating condition has been attributed to malfunctioning of the corneal epithelial stem cells visualized by a progressive deterioration of the stem cell environment, the palisades of Vogt [2] [3] [4] [5] . The break-down of the stem cell niche triggers conjunctivalisation and eventually opacification of the cornea [6] . The AAK reduces visual performance further and adds a chronic irritation and photophobia to the symptoms [7] . However, the reason for the development of AAK in patients is still unclear. Of special interest was to establish if surgical procedures triggered the AAK progression. The results however have been inconclusive due to the small amount of material and to the fact that surgery has developed towards less traumatic procedures [8] .
It has been shown [9] that vascular endothelial growth factor (VEGF) and its receptors are involved in the maintenance of the stem cell barrier preventing blood vessels to enter the corneal surface. VEGF is also known to influence nerve growth [10;11] which may be a contributing factor to PAX6 since the dosage of PAX6 itself is the main factor contributing to pathological pattern of corneal innervation in aniridia [12] . It has also been suggested [13] that nerve growth factor receptor TrkA is involved in the regulation of the normal stem cell turnover.
The expression levels of the proteins mentioned above in patient tears with aniridia are unknown. It was thus of interest to find out if these proteins and also other protein components of tear fluid were expressed differently in tears from eyes with aniridia compared to normal controls. In the present study, for the first time, we implemented 2-DE based comparative proteomics and 1-or 2-dimensional western blot for the analysis of changes in tear proteome in aniridia. The findings may help to identify molecules which can be useful for development of novel treatment strategies in symptomatic therapy of aniridia affected eyes. Thus, proteins with different abundance in tears between aniridia patients and healthy tears were identified.
Material and methods

Participants
A total 18 participants, 10 patients (20 eyes) with congenital aniridia from a well characterized Swedish cohort of patients (reviewed in [8] ) and 16 eyes that belong to 5 healthy family members without PAX6 mutation (aniridia) or any other ocular diseases and 3 healthy volunteers that belong to the same ethnic group of Caucasian as the other individuals were included in the present study. In order to obtain the best matched patients' samples with controls, the samples in the control group were collected from individuals with the identical genetic background as in the patient group.
Therefore similar number of samples used as controls for the patient group was collected inviting healthy family members without aniridia or other eye diseases. In that regard additional parameters, such as age, gender, past and current diagnoses of ocular infection or other ocular pathologies and medication were considered. Due to rare prevalence of aniridia in population it was difficult to obtain larger coherent cohort of patients and even control samples from individuals with that genetically identical background mentioned. Ethical approval was obtained from ethics committee of University Hospital at Linkoping University (Linkoping, Sweden) and informed consent was obtained from all participants prior to sample collection. The work described in this article has been carried out in accordance with the Declaration of Helsinki.
Tear sample collection and extraction of proteins from Schirmer's strips
Tear fluid from left and right eye of ten patients (n = 10) with diagnosed aniridia and group of 8 healthy individuals (n = 8), as described above, was collected using standard Schirmer's strips during clinical examination. Tear collection using Schirmer's strips was chosen as the most convenient method of sample collection for its reproducibility validated by several proteomic studies [14] [15] [16] [17] . This method is capable to provide high number of identified tear proteins with function in diverse processes, such as antioxidants, protein-folding proteins, proteins involved in the metabolism, immune response, and also proteins which can be used for the classification of cell structures (reviewed in [17] ). Moreover, the Schirmer's test provided important clinical data for the assessment of tear production, thus helping to exclude the samples from individuals with secondary eye pathologies, such as dry eye syndrome. The exclusion criteria in both groups were a Schirmer's test of less than 10 mm of moisture on the strip in 5 min, a current diagnosis of ocular infection, history of ocular or eyelid pathologies with exception of aniridia in the patient group, and the use of current ocular or systemic medication. Congenital aniridia is an inherited disease therefore disease duration for the each patient is identical with the patient`s age. The clinical data for each patient and healthy individual, if applicable, along with age, gender, and ethnicity are listed in Table 1 . After sample collection, wet Schirmer's strips with absorbed tears were immediately snap frozen and kept at -80 ºC to prevent protein degradation until analyzed. Before analysis, proteins absorbed on Schirmer's strips were extracted with 100 µl of solubilization buffer containing 20 mM Tris, 7 M urea, 2 M thiourea, 0.1 % CHAPS, 10 mM 1,4-dithioerythritol (SigmaAldrich Sweden AB, Stockholm, Sweden), 0.5% ampholytes 3-10 (Bio-Rad Laboratories, Hercules, CA, USA), and protease inhibitor cocktail (Complete mini, Roche Diagnostics Scandinavia AB, Stockholm, Sweden) and sonicated three-times for 30 sec, followed by additional incubation for 2 h on ice. After centrifugation (15,000 x g, 30 min, 4 ºC), which removed debris, the samples were desalted using 3 kDa cut-off centrifugal filter units (Millipore Ireland, Cork, IRL). The final sample volume was adjusted to 100 µl with the sample buffer (20 mM Tris, 7 M urea, 2 M thiourea, 4 % CHAPS, 10 mM 1,4-dithioerythritol (Sigma-Aldrich), 0.5% ampholytes 3-10 (Bio-Rad), and protease inhibitor cocktail (Complete mini) and the protein content was determined using the Bradford reagent (Pierce, Thermo Scientific, Rockford, IL, USA).
Two-dimensional electrophoresis
Isoelectric focusing (IEF) was carried out using ready-to-use immobilized pH gradient (IPG) strips (17 cm) with nonlinear pH range IPG 3-10 NL (Bio-Rad). The individual samples (50 µg of proteins) were loaded during rehydration of IPG strips in 300 µl (total volume) of IEF buffer (7 M urea, 2 M thiourea, 4 % CHAPS, 10 mM 1,4-dithioerythritol, 1.25 % IPG buffer pH 3-10 and traces of bromophenol blue, Sigma-Aldrich) for 18 h. IEF was carried out for a total 60 kVh (50 µA/IPG strip) using Multiphor II system (Pharmacia Biotech, Uppsala, Sweden). After IEF, the strips were stored at -80 ºC until run in the second dimension (SDS-PAGE). Prior to SDS-PAGE, the IPG strips were incubated in equilibration (EQ) solution [(6 M urea 
Image Capture Spot Quantitation and Statistical Analysis
Gels were fixed in 50 % methanol, 7 % acetic acid (Sigma-Aldrich) for 2 h followed by staining with SYPRO Ruby (Bio-Rad) for 12 h. Excessive dye was removed by incubation of gels in solution containing 10 % methanol, 7 % acetic acid and gels were scanned and the images were captured as 16-bit TIFF files for further analysis. The experimental dataset comprised of 36 two-dimensional gel images of tear fluid proteome from 36 eyes divided into patient group (20 eyes) and control group consisting of healthy individuals (16 eyes). Two gel images (obtained from two tear samples (left and right eye of the patient A4) were excluded from analysis due to remarkable different protein pattern caused probably by arterial leakage. Analysis of the gel images, including background subtraction, spot volume normalization, and differences in protein expression among the groups, was performed using PDQuest 8.01 software (Bio-Rad). All images were visually inspected for artifactual spots, and merged or missed spots. Each matched spot was manually inspected and confirmed on each individual gel. For the statistical analysis, the only spots which were present in all gels from the same group were included. The amount of protein in a spot was normalized in each gel by dividing the raw quantity of each spot by the total intensity value of all the pixels in the image. The normalized spot volume is referred to as abundance. Data are presented as mean ± SEM. The Anderson-Darling test of normality [18] was used to find the data that differed from normal distribution. Statistical differences between the groups were assessed using the Student`s t-test or the Mann-Whithey test with P < 0.01 considered as significant. The Mann-Whitney test was used for cases where data were not normally distributed. The statistical analysis was performed with commercial software SYSTAT 11 (Chicago, IL, USA). The Pearson correlation between proteomic data and clinical parameters for the patient group was performed with software Excel 2010 (Microsoft Inc., Redmond, WA, USA).
In-gel digestion and mass spectrometric identification
Excised protein spots from SYPRO Ruby stained gels were destained with 100 mM ammonium bicarbonate in 50 % acetonitrile (AcN, Sigma-Aldrich), washed with 100 % AcN and dried on The extracted peptides were dried on SpeedVac (Christ) and dissolved in 5 µl 0.1 % FA in 50 % AcN.
The resulting peptide mixtures were analyzed by LC-MS/MS using nano-flow HPLC system (EASYnLC; Bruker Daltonics, Bremen, Germany) on a 20 mm × 100 µm (particle size 5 µm) C18 pre-column followed by a 100 mm × 75 µm C18 column (particle size 5 µm) at a flow rate 300 nl/min, using a linear gradient starting with 0.1% FA (solvent A) and ending with 0.1% FA in 100% AcN (solvent B) for 45 min. The HTCultra PTM Discovery System (Bruker Daltonics, Bremen, Germany) was used for data acquisition. Raw data from tandem MS analyses were processed using DataAnalysis 3.4 software (Bruker Daltonics) and the resulting Mascot generic files were used for the search in NCBI protein database on the Mascot server (www.matrixscience.com). The search parameters were:
Taxonomy: "Homo sapiens"; Enzyme: trypsin with permission of one missed cleavage site; Fixed modification: "Carbamidomethyl (C)"; Variable modifications: "Protein acetylation" and "Oxidation (M)";
Peptide tolerance: ± 0.8 Da for MS data and ± 0.8 Da for MS/MS data. The significance threshold for MASCOT ion identification was set to P < 0.05. Proteins with at least one peptide passing the required bold red criteria were considered to be positively matched.
Immunoblot analysis of VEGF, NGF, and soluble TrkA
Due to limited protein concentration in tears as well as the limited availability of aniridia patients, for the immunoblot analysis of VEGF, NGF, and TrkA we prepared pooled samples from the same patients and control samples as were used in 2-DE proteomic analysis. These pooled samples were prepared as follows: control sample 1a (30 µg of proteins) by pooling of the equal quantity ( Stockholm, Sweden). The specific immunoreactivity was visualized using ECL detection kit (GE Healthcare, Uppsala, Sweden). Details for the analysis of NGF and TrkA levels are provided in the supplemental section since these proteins were not detected in tears of both aniridia patients and healthy subjects.
Clinical examination of patients and in vivo confocal microscopy
The cohort of aniridia patients and control subjects (if applicable, see Table 1 Table 1 . Moreover, a cornea-specific clinical in vivo confocal microscope (HRT3-RCM, Heidelberg Engineering, Heidelberg, Germany) was used to detect the presence of blood and lymph vessels in the patients corneas. The technique has been described in details previously [19] . Briefly, the 63x immersion objective lens was placed in contact with the topically anesthetized cornea through a drop of optical coupling medium (carbomer 2mg/g; Viscotears ® eye gel, THEA laboratories, France). The microscope field of view was aligned to the central or peripheral cornea, and depth was adjusted by a manual focusing ring. Laserscanned images were obtained in real time under software control, at various corneal locations and depths.
Results
The presented work provides comprehensive analysis of protein composition in the tears of patients with congenital aniridia and identifies differences in protein levels in patients' tears by comparing with healthy tears. Thus, two-dimensional map of tear proteome in aniridia has been established using IPG 3-10NL strips and 52 protein spots were analyzed and identified by LC-MS/MS (Fig. 1 , Supplemental Table 1 Table 1 . Two tear samples from total of 20 patient samples were excluded from analysis due to remarkable different protein pattern observed (sample A4, see Table   1 ). Only spots present in all gels of the same group (valid spots) were analyzed. Using stringent criteria the image analysis revealed 7 protein spots with P < 0.01 to be differently expressed in the tear fluid of aniridia patients compared with healthy individuals (Fig. 2, Table 2 ). Five of them were more abundant in healthy subjects, in particular α-enolase (P = 0.0071), peroxiredoxin 6 (P = 0.0044), cystatin S (P = 0.0041), gelsolin (P = 0.0078), and apolipoprotein A-1 (P = 0.0073). Two other spots were more expressed in the tear fluid of aniridia patients and were identified as zinc-α2-glycoprotein (P = 0.00997) and lactoferrin (P = 0.0053). The complete list and nomenclature of all the proteins identified in 2-DE analysis, particularly the sequence coverage and the identified peptides is given in the Supplemental Table 1 . The differentially expressed proteins were generally in weak correlation with the clinical parameters examined. Moderate correlation was found only in the case of peroxiredoxin 6, apolipoprotein A-1, α-enolase, and cystatin S with disease duration and for peroxiredoxin 6, α-enolase, and cystatin S with corneal sensitivity. The Pearson correlation between proteomic data and clinical parameters is provided in Table 3 .
Because the clinical examination of the patient cohort revealed abundant blood and lymph vessels with opaque corneas (Supplemental Fig. 3) , as the next step we analyzed expression of potential vascularization factors, such as vascular endothelial growth factor (VEGF), nerve growth factor (NGF), and a soluble form of the high affinity nerve growth factor receptor TrkA in the samples from the same patient and control cohorts as were used in 2-DE analysis. For this aim, highly sensitive and specific western blot analyses were required since we were unable to detect and visualize these proteins using 2-DE based comparative proteomics combined with SYPRO Ruby staining and consequent LC-MS/MS identification due to their low abundance in tears as they function in very low levels in autocrine and/or paracrine mechanisms. One-dimensional immunoblot analysis revealed elevated VEGF levels in the patients tears. The immunoreactivity was present at the band of ~ 80 kDa (Fig. 3a, b) , which is the molecular weight corresponding to c-form of VEGF (VEGF-C).
Moreover, the analysis using 2-D western blot has not only confirmed the results from 1-D immunoblot but has also identified two VEGF isoforms, both with higher abundance in the patients' tears. However, the isoform with the isoelectric point about 7.4 was in much higher abundance in the patients' tears than in the controls. Further analysis is needed to identify posttranslational modification responsible for this effect. The expression levels of NGF and TrkA were not detected in tears of both aniridia patients and healthy subjects (data not shown).
Discussion
Analysis of protein profile in tear fluid is important for biomarker identification and potentially useful in the assessment of prognosis or treatment of ocular pathologies. The present study identifies, for the first time, proteins in the tear fluid from patients with congenital aniridia. Using 2-DE analysis and LC-MS/MS we established 2-DE map of tear proteins in aniridia (Fig. 1, Supplemental Table 1 ) and identified proteins that were differently expressed in the tear fluid of patients when compared with the healthy tears. In order to obtain the most accurate results, no pooling of samples or sample fractionation and pre-enrichment protocols that may result in protein loss were used prior 2-DE analysis with the exception of the 3 kDa cut-off filtration which was required for the sample desalting.
Separate analysis of each individual sample has also the advantage of visual evaluation of protein patterns that show variation within the group. Thus, one patient (sample A4 from both eyes, see Table   1 ) was excluded from data analysis in this manner due to probable vascular leakage that was manifested by higher abundance of plasma proteins, such as serum albumin (Supplemental Fig. 1) .
By comparing the global protein expression in tear fluid we found 7 protein spots with P < 0.01 with different expression between patients and healthy subjects (Fig. 2, Table 2 , and Supplemental Fig. 2 ). The expression of 5 proteins was greater in the healthy subjects; α-enolase, peroxiredoxin 6, cystatin S, gelsolin, and apolipoprotein A-1.Two proteins, zink-α2-glycoprotein and lactoferrin, were found to be more expressed in aniridia patients. Additionally, due to defects in corneal innervation and pathological growth of blood and lymph vessels observed in the corneas of aniridia patients (Supplemental Fig. 3 ) we examined expression of VEGF, NGF, and soluble TrkA in the same patient and control cohorts using immunoblot analysis. Using the highly sensitive western blot analysis was required due to extremely low abundance of these proteins in the tear samples which prevented their detection in 2-DE gels with SYPRO Ruby stain and consequent LC-MS/MS identification. Using one-and two-dimensional western blot we have found greatly elevated VEGF levels in the tears of aniridia patients with the immunoreactivity present at the band of ~ 80 kDa which is the molecular mass corresponding to VEGF-C. VEGF-C is the member of VEGF family involved more specifically in the regulation of physiological and pathological growth of blood and lymphatic vessels [20] . Using 2-D immunodetection we confirmed the results obtained from 1-D western blot and, additionally, we were able to identify two VEGF isoforms with the similar molecular size of ~ 80 kDa present in higher levels in the patient tears. Moreover, one of these VEGF isoforms with isoelectric point pI ~ 7.4 was even in much higher abundance in the patients than in the control tears.
However, further investigation is needed to identify the process responsible for the observed posttranslational processing.
Additionally, we have also found that NGF, as another proangiogenic factor [21] , and the soluble NGF receptor TrkA are probably not involved in the pathophysiology of aniridia since they were not detected in both patients and control tears (data not shown).
In the text below we discuss, in some details, the possible functional roles of the proteins with altered expression in the patient tears, identified in both approaches, in the context of aniridia pathophysiology.
α-Enolase
α-Enolase is a highly conserved enzyme catalyzing the conversion of 2-phosphoglycerate to phosphoenolpyruvate in the process of glycolysis. The levels of enolase isozymes may serve as a diagnostic tool for assessment of the severity and outcome of certain pathological conditions, e.g. stroke, cardiac arrest or other neurological disorders, as in the case of neuronal-specific enolase in plasma [22] . In regard of α-enolase and its function in physiological or pathological conditions of eye, expression of this isozyme has been previously reported to be related to the limbal basal epithelium, as demonstrated by immunofluorescent microscopy [23] . In another study, an up-regulation of α-enolase has been found in the tear fluid of patients with dry eye syndrome [24] . In the present study α-enolase was down-regulated (0.54-fold) suggesting that its down-regulation is not related with tear disturbances often found in this disease but more likely as a result of impaired corneal epithelial function caused by mutations in the PAX6 gene [25] . However, further studies are needed for evaluation of this finding and usefulness of this potential biomarker for development of symptomatic therapy for aniridia patients.
Peroxiredoxin-6
Another protein which may be involved in maintaining of corneal transparency is a glutationdependent peroxidase, peroxiredoxin 6 . It has been demonstrated that the topical administration of this protein had inhibitory effect on VEGF expression, inflammation, and suppressed neovascularization and apoptosis in ultraviolet irradiated rat corneas [26] . The presence of proteins involved in the metabolism of reactive oxygen species, such as peroxiredoxins and catalase in the normal tear film [27] suggests their function in the defense against these highly reactive and toxic compounds. Moreover, oxidative stress has been demonstrated to be a significant factor contributing to chronic wound state and wound-healing delay of corneas in Pax6+/-mouse model [28] . We have found that peroxiredoxin 6 was down-regulated (0.69-fold) in the tears of aniridia patients when compared with healthy family members. Decreased expression of peroxiredoxin 6 may thus be associated to the elevated expression of VEGF in the tear fluid and to the increased corneal susceptibility to oxidative stress.
Cystatin S and Lactoferrin
Cystatins are naturally occurring inhibitors of cysteine proteinases. This function contributes to prevention of uncontrolled proteolysis and tissue damage [29] [30] [31] . The expression of these proteins in tears is also known to be reduced in several pathological conditions [32] [33] [34] [35] . Cystatin S and lactoferrin are components of the corneal and the conjunctival epithelial defense against bacterial and viral pathogens. Lactoferrin is an iron-binding protein with bacteriostatic effect by impeding of iron utilization by bacteria [31] . In the present study we have found the levels of cystatin S decreased in aniridia tears (0.54-fold). On the other hand, the levels of lactoferrin were increased (1.41-fold). It is tempting to hypothesize that the elevated expression of bacteriostatic lactoferrin in aniridia tears may be beneficial in corneal and conjunctival defense against pathogens compensating for a cystatin insufficiency.
Gelsolin
The gelsolin family of proteins is involved in cytoskeletal rearrangement controlling actin organization by binding, severing and capping of actin filaments [36] . In addition to their role in actin filament remodeling, these proteins play roles in many cellular processes, such as cell motility, apoptosis or regulation of gene expression [37] . The levels of gelsolin have been found to be up-regulated in the corneal epithelium of patients with keratoconus [38] . In the present study we found a decreased expression of gelsolin in tears from aniridia patients (0.69-fold). The decreased expression of this protein may contribute to the many defects attributed to the corneal epithelium in aniridia.
Zinc-α2-glycoprotein
Zinc-α2-glycoprotein (ZAG) is a 41 kDa protein which is secreted in various body fluids, such as plasma, saliva and tears with multifunctional roles including stimulation of lipid breakdown in adipocytes, and expression of immune response or insulin resistance [39;40] . The altered abundance of this protein in tears was found in several pathological eye conditions. For example, increased abundance of ZAG was found in the tears of keratoconus patients [15] , in patients with Grave's ophthalmopathy [41] or keratitis [42] . On the other hand, no significant changes of this protein were noticed in tears from patients with dry eye syndrome [43] . In the present study we have found elevated levels of ZAG in aniridia tears (1.4-fold). The exact role of up-regulated ZAG in aniridia is unknown but the alterations in the tear lipidome profile observed in patients with fungal keratitis [42] may suggest its possible role in the tear lipid degradation. The tear film break-up time in aniridic patients is often short [44] and here ZAG may play a role in changes the qualities of the lipid layer in the tear film.
Apolipoprotein A-1
Apolipoproteins are lipid-binding proteins which transport the lipids through the lymphatic and blood circulatory systems. Besides their lipid-transporting function, an anti-inflammatory effect of apolipoproteins has also been demonstrated [45;46] . Increased secretion of apolipoprotein A-I by lacrimal gland was reported in patients with advanced diabetic retinopathy [47] as well as in tears of patients with fungal keratitis [42] . In the present study, we have found a decreased content of apolipoprotein A-1 in the tear fluid of patients with aniridia (0.53-fold) contributing to an insufficiency in the anti-inflammatory potential of tear film in patients with aniridia. This may be one possible explanation for the elevated numbers of dendritic immune cells in the central cornea, even in the absence of evident signs of inflammation, suggesting on a subclinical form of inflammation in earlystage of aniridia associated keratopathy [2] .
Vascular endothelial growth factor (VEGF)
Pathological corneal vascularization or aniridia associated keratopathy is an associated ocular abnormality in aniridia patients (Fig. 3) . Corneal avascularity, which is a prerequisite for intact vision, is achieved by maintaining of low corneal levels of VEGF expression and strong expression of vascular endothelial growth factor receptor 3 (VEGFR-3) by corneal epithelium [48] . Up-regulation of both VEGF-C and VEGFR-3 has also been demonstrated in inflamed rat corneas [49] . In the present study we found greatly elevated expression of VEGF in the tear fluid of aniridia patients identified as the immunoreactive band of ~ 80 kDa, which is the molecular size corresponding to VEGF-C (Fig. 3a, b), suggesting a breakdown of balance between pro-and anti-angiogenic factors and stimulation of angiogenesis and lymphangiogenesis. Moreover, analysis of VEGF expression by two-dimensional western blot revealed that posttranslational processing of this protein may play a significant role in regulation involved in aniridia pathophysiology since we found highly up-regulated isoform with pI around 7.4 in the patient tears (Fig. 3b) .
Conclusion
The proteomic analysis of tears in patients with aniridia has identified proteins with significant differences in abundance when compared to healthy tears. Five proteins were down-regulated: α-enolase, peroxiredoxin 6, cystatin S, gelsolin, and apolipoprotein A-1. Two proteins were upregulated: zinc-α2-glycoprotein and lactoferrin. Likewise 80 kDa VEGF isoform corresponding to VEGF-C was found up-regulated using 1-and 2-dimensional western blot. NGF and the receptor TrkA were not detected. Further studies are needed to clarify the involvement of the identified proteins in aniridia pathophysiology and their potential as targets for the symptomatic therapy of this severe ocular condition. Table 2 and Suppl. Table 1 for more details). Abbreviations: A1-A10 = patients; C1-C8 = controls; F/M -female/male; R -right eye; L -left eye; N/Anot applicable; BUT -tear breakup time Notes: 1 -patient; 2 -healthy relatives with the same genetic background but without PAX6 mutation; 3 -volunteers; a -ethnicity: Caucasian; b -disease duration is the same as the age of each of the patient due to inherited feature of congenital aniridia; c -confirmed PAX6 mutation; n -no therapy 
